Doxycycline Hyclate

Particle Engineering Technologies
We specialize in particle engineering technologies to address oral bioavailability, lung delivery, modified release and taste masking. In each technology we can support you from proof of concept to commercial manufacturing.
Wet Polishing
Hovione developed ...

Aclidinium Bromide for development trials with customized Particle Design, resulting in Inhalation grade material with highly customizable PSD to befit your application.
Our technology and expertise yields unmatched impurity profiles with highly reproducibility between batches, resulting in ...

ROUTE OF ADMINISTRATION: Inhalation, Nasal, Oral, Topical
Hovione is a world leader in regulated markets offering APIs for human applications for over 60 years.
With an unblemished regulatory track record Hovione makes available offer an unrivalled technological range to provide the API with...

Hovione has over 57 years of experience in the manufacture of corticosteroids with uncompromising quality and an unblemished Regulatory track record.
With an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size dist...

Hovione has over 57 years of experience in the manufacture of corticosteroids. Injectable quality available on demand from the European producer with an unblemished Regulatory track record.
Approved branded and generic human applications.
Sterile material to be avai...

Corticosteroid ROUTE OF ADMINISTRATION: Ophthalmic, Injectable, TopicalREGULATORY STATUS: US DMF, JP DMF

Market leaders in regulated markets such as the US, Europe and Japan with multiple manufacturing sites.
An API with a high grade quality manufactured in dedicated facilities for human applications.
Customizable particle size distribution to fit end application and formulation ...

ROUTE OF ADMINISTRATION: Inhalation, Oral, Topical 

REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Injectable

REGULATORY STATUS: GMP, TECK PACK

ROUTE OF ADMINISTRATION: Injectable

REGULATORY STATUS: DEV, TECH PACK

Fluticasone Furoate, crystalline form I for development trials with tailor made Particle Design to best fit your application, yielding Inhalation grade material, featuring a near-perfect particle size distribution reproducibility and low span batch after batch. Low amorphous content and high stability with...

Hovione has a proven track record in developing and manufacturing high performance APIs for the most demanding applications such as inhalation.
With an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a customizable, near-perfect partic...

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.

Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

One-Site-Stop

This sun, this sea is what inspired the Portuguese to be the first to sail around the world five centuries ago. Today, discovery still requires courage, a willingness to take risk, and the best technologies. At Hovione this is what we do. We give clients what they cannot find elsewhere, we do well what is difficult. 
We work to help develop new and better medicines. Chemistry, processing and mathematical models are subjects we master, but it all begins and ends with the people. The almost 2000 committed, creative, rigorous, highly qualified team members coming from all parts of the world in which we operate. To contribute to their talent development is one of our major challenges and achievements.

Hovione #WeFightBack

Introduction to Hovione’s new formulation screening platform by Spray Drying Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development Get to know more about Hovione’s extensive expertise in Spray Drying This session was originally broadcast live as part of CPHI North America 2021

WATCH WEBINAR

The Coming of Age of Amorphous Solid Dispersions

In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.

READ ARTICLE The Coming of Age of Amorphous Solid Dispersions In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.

WATCH VIDEO For more than 60 years, Hovione has been dedicated to improving the lives of millions of patients, collaborating with our clients to create great medicines. In a time we need to adapt to new – and unprecedented – challenging circumstances, all our doors are open with virtual tours and Hovione team members are working enthusiastically with our partners, to solve complex problems and deliver solutions. Get to know more about us: During the 10 days’ event meet with Hovione’s experts safely online.